Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Mazzola

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neurotoxicology|November 14, 2002
Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders?Jennifer L Mazzola, Michael A Sirover
Brain Research. Molecular Brain Research|May 15, 2002
Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblastsJennifer L Mazzola, Michael A Sirover
Journal of Neuroscience Research|December 28, 2002
Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblastsJennifer L Mazzola, Michael A Sirover
Biochimica Et Biophysica Acta|June 28, 2003
Subcellular localization of human glyceraldehyde-3-phosphate dehydrogenase is independent of its glycolytic functionJennifer L Mazzola, Michael A Sirover
Biochimica Et Biophysica Acta|February 18, 2005
Aging of human glyceraldehyde-3-phosphate dehydrogenase is dependent on its subcellular localizationJennifer L Mazzola, Michael A Sirover
Journal of Neuroscience Methods|July 21, 2004
Subcellular analysis of aberrant protein structure in age-related neurodegenerative disordersJennifer L Mazzola, Michael A Sirover
Expert Opinion on Drug Safety|June 7, 2005
The role of antiplatelet therapy in the management of acute coronary syndromesGregory A Volturo, Jennifer L Mazzola, Karin Przylenk
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 2, 2003
Guidelines for liposomal amphotericin BJennifer L Mazzola, Paul P Belliveau, Sarah H Cheeseman
Journal of Clinical Psychopharmacology|May 7, 2005
Levofloxacin-related seizure activity in a patient with Alzheimer's disease: assessment of potential risk factorsSteven B Bird, Patrick G Orr, Jennifer L Mazzola, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neurotoxicology|November 14, 2002
Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders?Jennifer L Mazzola, Michael A Sirover
Brain Research. Molecular Brain Research|May 15, 2002
Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblastsJennifer L Mazzola, Michael A Sirover
Journal of Neuroscience Research|December 28, 2002
Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblastsJennifer L Mazzola, Michael A Sirover
Biochimica Et Biophysica Acta|June 28, 2003
Subcellular localization of human glyceraldehyde-3-phosphate dehydrogenase is independent of its glycolytic functionJennifer L Mazzola, Michael A Sirover
Biochimica Et Biophysica Acta|February 18, 2005
Aging of human glyceraldehyde-3-phosphate dehydrogenase is dependent on its subcellular localizationJennifer L Mazzola, Michael A Sirover
Journal of Neuroscience Methods|July 21, 2004
Subcellular analysis of aberrant protein structure in age-related neurodegenerative disordersJennifer L Mazzola, Michael A Sirover
Expert Opinion on Drug Safety|June 7, 2005
The role of antiplatelet therapy in the management of acute coronary syndromesGregory A Volturo, Jennifer L Mazzola, Karin Przylenk
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 2, 2003
Guidelines for liposomal amphotericin BJennifer L Mazzola, Paul P Belliveau, Sarah H Cheeseman
Journal of Clinical Psychopharmacology|May 7, 2005
Levofloxacin-related seizure activity in a patient with Alzheimer's disease: assessment of potential risk factorsSteven B Bird, Patrick G Orr, Jennifer L Mazzola, et al.
Pageof 1